Biomarker-guided de-escalation of empirical therapy is associated with lower risk for adverse outcomes

被引：0
|
作者：
Philipp Schuetz
Beat Mueller
机构：
[1] Kantonsspital Aarau,Medical University Department
来源：
Intensive Care Medicine | 2014年 / 40卷
关键词：
Antibiotic Therapy; Propensity Score; Intensive Care Unit Patient; Procalcitonin; Prospective Randomized Trial;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：141 / 141
相关论文
共 50 条
  • [41] Influences of de-escalation antibiotic therapy on clinical cure rate, adverse reaction, and endotracheal intubation rate of severe pneumonia patients.
    Mao, Long-Jun
    Zhang, Ping
    He, Xiao-Yu
    BIOMEDICAL RESEARCH-INDIA, 2017, 28 (09): : 4058 - 4061
  • [42] Aggressive de-escalation of adjuvant Therapy in HPV-associated Oropharyngeal Carcinoma. Is Half of everything Enough? Comment
    Hecht, Markus
    Semrau, Sabine
    STRAHLENTHERAPIE UND ONKOLOGIE, 2020, 196 (05) : 493 - 494
  • [43] Opportunities for de-escalation of aspirin therapy in patients with atrial fibrillation at high stroke risk receiving direct oral anticoagulants
    Li, Angela
    Brock, Zachary
    Glover, Jon
    JOURNAL OF THE AMERICAN PHARMACISTS ASSOCIATION, 2024, 64 (04)
  • [44] Escalation/de-escalation of initial empiric ventilator-associated pneumonia therapy: Interim results from the assessment of local antimicrobial resistance measures study
    Kollef, MH
    Niederman, MS
    Leeper, KV
    Morrow, LE
    Anzueto, A
    Benz-Scott, L
    Rodino, FJ
    CHEST, 2004, 126 (04) : 718S - 718S
  • [45] Targeted Therapy as a Potential De-Escalation Strategy in Locally Advanced HPV-Associated Oropharyngeal Cancer: A Literature Review
    Chitsike, Lennox
    Duerksen-Hughes, Penelope J.
    FRONTIERS IN ONCOLOGY, 2021, 11
  • [46] Ventilator-associated pneumonia: the influence of bacterial resistance, prescription errors, and de-escalation of antimicrobial therapy on mortality rates
    Souza-Oliveira, Ana Carolina
    Cunha, Thulio Marquez
    da Silva Passos, Liliane Barbosa
    Lopes, Gustavo Camargo
    Gomes, Fabiola Alves
    de Brito Roder, Denise Von Dolinger
    BRAZILIAN JOURNAL OF INFECTIOUS DISEASES, 2016, 20 (05): : 437 - 443
  • [47] Characteristics and outcomes of anti-infective de-escalation during health care-associated intra-abdominal infections
    Montravers, Philippe
    Augustin, Pascal
    Grall, Nathalie
    Desmard, Mathieu
    Allou, Nicolas
    Marmuse, Jean-Pierre
    Guglielminotti, Jean
    CRITICAL CARE, 2016, 20
  • [48] Characteristics and outcomes of anti-infective de-escalation during health care-associated intra-abdominal infections
    Philippe Montravers
    Pascal Augustin
    Nathalie Grall
    Mathieu Desmard
    Nicolas Allou
    Jean-Pierre Marmuse
    Jean Guglielminotti
    Critical Care, 20
  • [49] Dose and Volume De-Escalation for HPV-Positive Oropharyngeal Cancer is Associated with Favorable Post-Treatment Functional Outcomes
    Foster, C. C.
    Seiwert, T. Y.
    MacCracken, E.
    Blair, E. A.
    Agrawal, N.
    Melotek, J. M.
    Portugal, L.
    Brisson, R. J.
    Gooi, Z.
    Spiotto, M. T.
    Haraf, D. J.
    Vokes, E. E.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2019, 105 (01): : E419 - E419
  • [50] Escalation of Immunosuppressive Therapy for Inflammatory Bowel Disease Is Not Associated With Adverse Outcomes After Infection With Clostridium difficile
    Lukin, Dana J.
    Lawlor, Garrett
    Hudesman, David P.
    Durbin, Laura
    Axelrad, Jordan E.
    Passi, Monica
    Cavaliere, Kimberly
    Coburn, Elliot
    Loftus, Michelle
    Jen, Henry
    Feathers, Alexandra
    Rosen, Melissa H.
    Maker, Lisa B.
    Swaminath, Arun
    INFLAMMATORY BOWEL DISEASES, 2019, 25 (04) : 775 - 781
12345